Table 1.

Profiles of the Patients with Lymphatic Malformations

Patient no./sex	Age of start treatment	Localization	Symptoms	Duration of treatment (mos)	Tumor size (mm)		Reduction ratio (%)
					Before administration	After administration
Macrocystic
1/M	4 mos	Head	Swelling	11	46 × 20 × 40	28 × 15 × 38	38.7
2/M	2 yrs, 5 mos	Neck	Swelling	8	18 × 38 × 41	13 × 34 × 55	86.7
3/F	2 yrs, 10 mos	Neck	Swelling	7	20 × 17 × 15	19 × 16 × 17	101.3
4/M	1 yr, 8 mos	Chest	Swelling	5	51 × 11 × 36	44 × 10 × 31	67.5
Mixed micro‐ and macrocystic
5/F	1 yr, 1 mos	Shoulder	Swelling	12	25 × 20 × 26	11 × 8 × 11	12.4
6/M	3 yrs, 5 mos	Chest	Swelling	5	60 × 24 × 62	16 × 16 × 56	16.1
7/F	4 yrs, 4 mos	Cheek	Swelling	5	98 × 35 × 26	46 × 30 × 10	15.5
8a/F	3 mos	Chest	Swelling	5	38 × 24 × 37	38 × 28 × 31	97.7

^aCombined with capillary‐lymphatic malformation.